Summary. The incidence rate of juvenile Type i (insulindependent) diabetes in France was reported as the lowest in Europe 13 years ago, but during the recent years increasing rates have been observed in different European countries. A prospective programme has been designed to study the incidence rate of Type 1 diabetes in patients up to 20 years of age in four regions located in the north and south of France (population < 20 years = 2.31 million inhabitants; 15% of the French population). All cases were independently identified by four specially trained research assistants through hospital admission files, paediatricians, diabetologists and general practitioners. A specific questionnaire was filled out for each newly diagnosed case. Degree of ascertainment was 96% with the data from S6curit6 Sociale, the French National Health Insurance. In 1988, 166 cases of juvenile Type I diabetes were identified. The incidence rate was 7.17 cases per 105 children (95% confidence interval=6.1-8.2/105). The values were not statistically different among the four regions. Age specific incidence rates were as follows: 0-4years=3.8; 5-9 years = 8.0; 10-14 years = 9.7 and 15-19 years = 7.3/105. Sex ratio was 1.2 (male/female). These data indicate that incidence of juvenile Type i diabetes in France was higher in 1988 than previously reported but remains lower than in Northern Europe. This is consistent with the concept of a north to south gradient of the disease.
Type 1 (insulin-dependent) diabetes mellitus is a chronic disease occurring during childhood in most cases. Although considerable advances have been made during the last decade, the aetiology of Type 1 diabetes remains unknown.
One puzzling observation is the variation in incidence from one country to another. Such differences have been reported in Europe generating the concept of a northsouth gradient of Type I diabetes incidence [1] . Nordic countries exhibit the highest incidence rates [2, 3] . A Finnish child would have a eight-fold increased risk of developing Type I diabetes before the age of 15 [4] compared to a French child.
In France, incidence data were assessed in the 1970's in two different surveys, providing the lowest observed rate in Europe: 3.7/105 inhabitants under 15 for the whole country, and 4.7 in the area of Lyon [5, 6] . The method of case catchment differed in the two studies (prospective and retrospective, respectively). This variation in methodology is frequently encountered in incidence studies, mainly due to the location of the surveys and the health care systems, and makes it difficult to comprehend the meaning of the geographical differences. Moreover, Type i diabetes incidence has been described as rapidly increasing over the last three decades in some countries in Europe [3, 7, 8, 9] and in North-America [10] .
In 1988, a programme was initiated in France to accurately and prospectively document the incidence data of Type i diabetes for individuals under the age of 20. The study was run in four regions with the agreement of the authorities. The purpose was to obtain reliable incidence rates and to establish a data base for other evaluations in the near future.
Subjects and methods

Case catchment
Figure i shows the four French counties included in the study: Haute-Norrnandie (West), Basse-Normandie (West), Lorraine (East) and Aquitaine (South), covering an area of 94,800 km 2 (17% of the total surface area of the country). 
Case definition
All diabetic patients diagnosed between 1 January and 31 December 1988, and born between 1 January, 1969 and 31 December, 1988 were included. The current address had to be within the defined area, for at least six months prior to diagnosis. Diabetes was defined according to the World Health Organisation criteria [11] . Type 1 diabetes was defined as the presence of ketonuria, (or ketoacidosis) and the need for permanent insulin therapy. The date of the first insulin injection was kept as the date of inclusion in the study. Secondary diabetes and maturity onset diabetes of the young (MODY) were exluded.
Study design
Case catchment was completed by four research assistants located in each region and specially trained for the study. They were in charge of identifying all the new cases, meeting the families and filling in a specific questionnaire. These questionnaires gathered information on the history of the disease, the initial care and the sociodemo-C. Levy-Marchal et al.: Incidence of Type I diabetes in France graphic status of the cases. Ethnicity of a given child was defined by the country of birth of the parents. Assuming that most of the patients are hospitalized at the onset of insulin therapy in France, we chose the various hospital units for children and adult care (Paediatrics, Diabetology, Internal Medicine, Gastroenterology, Intensive care) as the primary source. In order to ensure an exhaustive census, contact was also established with the private hospitals and the practitioners in private practice (general practitioners and consultants). The frequency and the type of contacts were chosen according to the probability for a given physician to identify a new diabetic case: visits, telephone calls, mail. Moreover, regular meetings were organized in each region, the year prior to and the year of the study, to discuss the protocol and to inform the local physicians about the results of this collaborative work.
All record forms were sent to the central level (INSERM Units) where inclusion criteria, information validity and data analysis were anonymously ascertained by the coordination team.
Approval for the study was obtained from the necessary French authorities (Insitut National de la Sant6 et de la Recherche M6di-cale, Caisse Nationale d'Assurance Maladie, Commission Nationale Informatique et Libertds).
Ascertainment
Data from the French national health insurance, S6curit6 Sociale, were elected as the secondary source of information because more than 90% of the people in the country are registered with this insurance. Either of the parents' insurance covers their childrens' medical expenses. The system is divided into three independent categories according to the professional activity of the individuals (salaried, independent or agricultural activity). The "General Regimen" covers more than 80% of the French population, e.g. the salaried category. Type 1 diabetes, because it is a chronic disease, benefits from a special reimbursement rate for medical expenses. Therefore, Type i diabetic patients are likely to identify themselves to S6curit6 Sociale.
Ascertainment over the primary source was performed in collaboration with the physicians of the "General Regimen" of Securit6 Sociale at each regional level.
Population base
The population base was calculated using the data from Institut National de la Statistique et des Etudes Economiques (INSEE). 2.314million subjects were under the age of 20years (eg born 1January, 1969-31December, 1988) in the four counties with 1.187 million males and 1.127 million females (sex ratio: 1.05). They represented about 15% of the French population under 20 years. In each space of the Table are 
Statistical analysis
Data management and statistical analysis were carried out using a general programme for medical data on the computer VAX 8630 from the National Center for Data Processing of INSERM. Chisquare (X 2) test was used for comparisons of percentages.
Results
Incidence rate
The primary source identified 166 new cases of Type 1 diabetes in 1988. At the time of diagnosis 154 patients were hospitalised, nine were under ambulatory care by private practitioners, and for three cases no information was available. The incidence rate was 7.17 for 105 inhabitants under age 20 (95% confidence interval: 6.1-8.2/105). There were 141 children of French origin, 18 non-European Caucasian (Northern Africa), six European Caucasian (Southern Europe) and one Black. More male than female children were newly diagnosed as Type i diabetic patients, although the sex ratio (1.27:1) was not significantly different from the general population. Incidence rates were 7.8 and 6.5/105 in male and female children respectively. There was no significant variation in incidence according to the regions (Table 1) , although the southern region Aquitaine exhibited the highest rate (8.6/105).
Significant variations in incidence were observed with age (X 2 = 14.2;p < 0.01), youngsters (0-4 years) exhibiting the lowest rate (3.8/105 ) ( Table 2 ). The annual incidence rate was 7.13/105 (95% confidence limits: 5.8-8.4/105 ) in the age interval 0-14 years. Figure 2 shows that the patterns of Type i diabetes occurrence with respect to age were not similar in girls and boys. Two cases were diagnosed in girls during the neonatal period and were found to be persistent cases of Type 1 diabetes. The incidence increased gradually to a peak at 10 years, and decreased rapidly thereafter. In boys, several peaks were observed among a rather small number of incident cases during the year of observation, at ages 6 and 10 with a maximum at 15, followed by a progressive decline thereafter.
No significant variation in incidence was recorded according to the month of diagnosis (Fig. 3) .
Ascertainment
Among the 166 cases, 136 belonged to families registered with the "General Regimen" of Sdcurit6 Sociale. The ascertainment was based on this group. Five additional cases were identified by S6curit6 Sociale only, providing a degree of ascertainment of 96% with the primary source. Therefore, the incidence rate would be 7.39/105 under 20 years of age. None of the features identified the five children as a group. Apparently, the lack of catchment by the primary source occurred at random. Their age ranged from 10-18 years. Three belonged to Aquitaine and two to Basse Normandie 9 Two were hospitalized outside the given county and two were hospitalized within the county with a critical and difficult medical history at the time of diagnosis. The last case had inadvertently not been declared by the physician. [6] . In both studies validation was not made possible with S6curit6 Sociale. Since Type 1 diabetes is a rare disease the method of case catchment and the information source for ascertainment are of prime importance for the calculation of incidence rates. Our prospective study was based upon a direct collaboration with any physician likely to diagnose Type i diabetes at each regional level.
The goal was easily reached with the numerous hospital units where more than 90% of the patients were admitted at the onset of insulin therapy. Contacting all of the physicians in private practice ( = 15,000) was more arduous and critical. All attempts were therefore made to inform the practitioners before and during the study through the medical newspapers, mailings and direct contact, as often as necessary.
S6curit6 Sociale provides a reliable secondary source of information because chronic diseases are clearly identified due to 100% reimbursment for medical expenses. Moreover, the registration with this national health insurance is mandatory in France, especially for salaried people. With the collaboration of S6curit6 Sociale, comparison between the two sources of data was extensive in the four regions with a high degree of ascertainment. Therefore, few new diabetic cases are likely to be missed in 1988. Data indicate that the five cases caught by S6-curit6 Sociale only, and not by the primary source, were not characterized by any special feature, and did not attest for a bias for the catchment of incident cases.
The discrepancy in methodology and case catchment might account for the difference in incidence rates between the 1970's and 1988. The higher rate observed in 1988 in France, however, may also represent temporal increase as it has been reported over the last three decades in some European countries [3, 7, 8] .
The French incidence rate appears to be among the lowest in Europe. Only Poland, a country of the same latitude as France, exhibits a similar rate in a recent prospective study [12] . The rate in Aquitaine (8.6/105 ) however was lower than in northern Italy (Aosta valley: 11.6/105 ) for the same age interval [13] although the latter have been calculated within a very small and specific area. The Lombardy register very recently provided a much lower rate (4.9/105 ) [14] . The incidence in Lorraine was lower than in Luxembourg (10.6/105 for 0-15 years) and these two regions are only separated by their border [15] . These data suggest that the overall concept of north-south gradient of incidence may be balanced by some regional dusters.
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The different regions in France which our study covered comprised about one fifth of the whole country. France is a country with a wide variety of regional geographic, demographic and climatic features. The four elected counties illustrate this diversity. Lorraine is an industrial area, located inland. Aquitaine has a warm climate with a high wine production. Basse-and Haute-Normandie are both located near the sea with agricultural and mixed agricultural-industrial productions, respectively. Shifts in population are known to occur within a given county. But they were of very little importance outside of the counties (small percentage of the counties populations) when assessed in the early 1980's. Regional differences in incidence rates were observed although they were not significant. This has already been reported in several European countries: Scotland [16] , the Netherlands [17] , Norway [18] , Denmark [19] . However, the lack of statistical significance in the French study may be due to the small number of incident cases recruited over one year of observation, leading to a small power associated with large 95% confidence intervals. This restriction stands also for age variation of incidence, although most of our results are consistent with previous reports.
The variation of Type i diabetes incidence with age has been described in most of the incidence studies. The percentage of cases diagnosed between 0-4 years was the lowest, similar to that previously reported in France [5, 6] . A specific increase in this age group however, has been reported in most recent European surveys [3, 15] . Our results indicated a peak of Type 1 diabetes occurrence between 9-12 years, around the pubertal age, earlier than that described by Lestradet et al. (11-14 years) . This is in keeping with the observations made in Great Britain where Type i diabetes prevalence data suggested an earlier diagnosis or manifestation of Type 1 diabetes during childhood without an overall increase in the number of cases [20] . After the pubertal period we observed only a slight decline of the incidence rate (15-19 years: 7.3/105). In most of the studies related to Type 1 diabetes incidence the age limit for case catchment was 14 years. We deliberately extended this to 19 years. This made the study somewhat more complex because recruitment of cases had to be extended to adult centres. Although the incidence rate in the age group 15-19 years was not different from the total population, a decline was apparent from 15 years onwards. The smaller number of cases in this age group is apparently not due to a mis-catchment. The proportion over the overall incident cases (47/166 = 28%) is at the same order of magnitude as previously reported in earlier 0-19 years incidence studies in several European countries, as for example in England [7] , Luxembourg [15] , the Netherlands [17] and Finland [4] . This pattern argued in favour of a general figure of the Type I diabetes incidence as described by Gamble [21] with a rapid increase up to the pubertal peak with progressive decline thereafter, until the age 35-40 years when new cases of the disease are known to be uncommon [22] .
Efforts are currently underway to accurately calculate incidence rates of juvenile Type 1 diabetes in many European countries, using a uniform prospective methodology, which would enable values to be established as accurately c. Levy-Marchal et al.: Incidence of Type I diabetes in France as possible. This work was set up within the framework of the Eurodiab project in which France is taking part. Eurodiab, which is a large project of the European Economic Community on epidemiology of diabetes, will provide an opportunity to validate and perhaps further understand the geographical variation of Type 1 diabetes incidence. As far as temporal variation is concerned our methodology should provide a reliable data base to assess the secular trend for the next decades.
